
Monday, May 20, 2024 5:57:50 PM
On September 18, 2023, the Company executed and closed a definitive business
combination agreement with Sagaliam Acquisition Corp. selling the operating
subsidiaries Virogenetics, Inc. and Biogenysis, Inc. in a stock transaction valued at
$360 million. This left the Company with no operating subsidiaries. The Company is
currently formulating a new business strategy and searching for target acquisitions
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM